NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ACTINOGEN MEDICAL LIMITED (ACW)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
ACTINOGEN MEDICAL LIMITED18/11/2015
ACTINOGEN LIMITED18/11/2015

Shareholder links

Our website ranking of ACW: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000ACW3
Address: Suite 901 Level 9 109 Pitt Street SYDNEY, NEW SOUTH WALES 2000
Tel:  + 61 2 9251 5620Fax: + 61 8 9321 1204

Date first listed: 16/10/2007
Company Secretary: Peter Webse
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Commercialisation of bioactive compounds

News & Events

Expand this box to read and print

name changed from Actinogen Limited

18/11/2015

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    03/11/2022Steven Gourlay750,000$0.125$93,508
    20/05/2022Geoffrey Brooke340,000$0.075$25,363
    12/05/2022Steven Gourlay2,000,000$0.064$128,240
    24/03/2021George Morstyn2,550,000$0.028$71,783
    01/06/2018George Morstyn200,000$0.051$10,282

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Geoffrey BrookeNon Exec Chairman01/03/2017
    Steven GourlayManaging Director, CEO15/03/2021
    Will SouterCFO05/02/2024
    Nicki VasquezIndependent Director01/03/2023
    George MorstynNon Exec Director01/12/2017
    Malcolm McComasNon Exec Director04/04/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Jeff CarterCFO28/09/202030/11/2023
    Bill KetelbeyManaging Director, CEO18/12/201408/02/2021
    Jason LoveridgeChairman27/08/201428/11/2018
    Anton UvarovNon Exec Director16/12/201314/08/2017
    Martin RogersExecutive Chairman28/11/201430/11/2016
    Brendan de KauweNon Exec Director24/09/201318/12/2014
    Daniel ParasilitiNon Exec Director24/09/201327/08/2014
    David ZoharExecutive Director12/10/200716/12/2013
    Zhukov PervanExecutive Chairman12/10/200724/09/2013
    Simon EnglandNon Exec Director18/07/200724/09/2013
    Alan MortonDirector18/07/200724/09/2013
    David KeastDirector01/11/200324/09/2013

    Date of first appointment, title may have changed.